Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

A novel type of immunoblocking as a means to cure autoimmunne diseases

Reference number
Coordinator Holdingbolaget vid Göteborgs universitet AB - GU Holding Kompetens AB
Funding from Vinnova SEK 900 000
Project duration April 2009 - September 2010
Status Completed

Last updated 25 November 2019

Reference number 2009-00463

Page statistics